227 related articles for article (PubMed ID: 17877357)
1. Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.
Shavit M; Peri D; Manna CM; Alexander JS; Tshuva EY
J Am Chem Soc; 2007 Oct; 129(40):12098-9. PubMed ID: 17877357
[No Abstract] [Full Text] [Related]
2. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
3. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
Manna CM; Tshuva EY
Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
[TBL] [Abstract][Full Text] [Related]
4. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
5. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
6. Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.
Gansäuer A; Winkler I; Worgull D; Lauterbach T; Franke D; Selig A; Wagner L; Prokop A
Chemistry; 2008; 14(14):4160-3. PubMed ID: 18384037
[No Abstract] [Full Text] [Related]
7. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
[TBL] [Abstract][Full Text] [Related]
8. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
9. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
[TBL] [Abstract][Full Text] [Related]
11. A marked synergistic effect in antitumor activity of salan titanium(IV) complexes bearing two differently substituted aromatic rings.
Glasner H; Tshuva EY
J Am Chem Soc; 2011 Oct; 133(42):16812-4. PubMed ID: 21967133
[TBL] [Abstract][Full Text] [Related]
12. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
[TBL] [Abstract][Full Text] [Related]
13. Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity.
Afrasiabi Z; Sinn E; Lin W; Ma Y; Campana C; Padhye S
J Inorg Biochem; 2005 Jul; 99(7):1526-31. PubMed ID: 15927263
[TBL] [Abstract][Full Text] [Related]
14. Synthetic route to dinuclear platinum(II) complexes [{trans-PtCl(NH3)2}2(mu-L)]2+ (L = aliphatic or heterocyclic diamine) as potential antitumor agents, exploiting the mutual activation of hydroxido ligands and ammonium groups.
Chopard C; Lenoir C; Rizzato S; Vidal M; Arpalahti J; Gabison L; Albinati A; Garbay C; Kozelka J
Inorg Chem; 2008 Oct; 47(20):9701-5. PubMed ID: 18817377
[TBL] [Abstract][Full Text] [Related]
15. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Vock CA; Ang WH; Scolaro C; Phillips AD; Lagopoulos L; Juillerat-Jeanneret L; Sava G; Scopelliti R; Dyson PJ
J Med Chem; 2007 May; 50(9):2166-75. PubMed ID: 17419606
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer activity of cyclic amine and thiaether metal complexes.
Medvetz DA; Stakleff KD; Schreiber T; Custer PD; Hindi K; Panzner MJ; Blanco DD; Taschner MJ; Tessier CA; Youngs WJ
J Med Chem; 2007 Apr; 50(7):1703-6. PubMed ID: 17343369
[TBL] [Abstract][Full Text] [Related]
17. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic dinuclear titanium-salan complexes: structural and biological characterization.
Immel TA; Grützke M; Batroff E; Groth U; Huhn T
J Inorg Biochem; 2012 Jan; 106(1):68-75. PubMed ID: 22112842
[TBL] [Abstract][Full Text] [Related]
19. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
